[
  {
    "ts": "2025-11-17T12:17:00+00:00",
    "headline": "AbbVie Stock Falls 4% -- What Investors Need to Know",
    "summary": "It's no reason to stay up at night.",
    "url": "https://www.fool.com/investing/2025/11/17/abbvie-stock-falls-4-what-investors-need-to-know/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "309dccb0-e53e-3e82-8aec-f5d1e2c5c81a",
      "content": {
        "id": "309dccb0-e53e-3e82-8aec-f5d1e2c5c81a",
        "contentType": "STORY",
        "title": "AbbVie Stock Falls 4% -- What Investors Need to Know",
        "description": "",
        "summary": "It's no reason to stay up at night.",
        "pubDate": "2025-11-17T12:17:00Z",
        "displayTime": "2025-11-17T12:17:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/5ccbd7c905c405afcc20a1b36fce1919",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A healthcare professional giving a patient medicine.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4ajkwvTiuZJEXURKdZHdNg--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/5ccbd7c905c405afcc20a1b36fce1919.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8UGz92YA6h1XHDGx5IiNhw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/5ccbd7c905c405afcc20a1b36fce1919.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/17/abbvie-stock-falls-4-what-investors-need-to-know/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-stock-falls-4-investors-121700186.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-17T12:01:00+00:00",
    "headline": "LUPRON DEPOT速 new strength receives Health Canada Approval for the Treatment of Advanced Prostate Cancer",
    "summary": "AbbVie (NYSE: ABBV) announced today that a new 6-month 45mg LUPRON DEPOT速 (leuprolide acetate for extended-release injectable suspension) strength has received Health Canada approval for the treatment of advanced prostate cancer. LUPRON DEPOT is now available in four dosing options: 7.5 mg (1-Month), 22.5 mg (3-Month), 30 mg (4-Month), and 45 mg (6-Month).1 LUPRON DEPOT was initially approved by Health Canada for advanced prostate cancer in 1989, providing 36 years of proven clinical use in Cana",
    "url": "https://finance.yahoo.com/news/lupron-depot-strength-receives-health-120100885.html",
    "source": "CNW Group",
    "provider": "yfinance",
    "raw": {
      "id": "06284710-4611-3ff4-8676-d648693eff1c",
      "content": {
        "id": "06284710-4611-3ff4-8676-d648693eff1c",
        "contentType": "STORY",
        "title": "LUPRON DEPOT速 new strength receives Health Canada Approval for the Treatment of Advanced Prostate Cancer",
        "description": "",
        "summary": "AbbVie (NYSE: ABBV) announced today that a new 6-month 45mg LUPRON DEPOT速 (leuprolide acetate for extended-release injectable suspension) strength has received Health Canada approval for the treatment of advanced prostate cancer. LUPRON DEPOT is now available in four dosing options: 7.5 mg (1-Month), 22.5 mg (3-Month), 30 mg (4-Month), and 45 mg (6-Month).1 LUPRON DEPOT was initially approved by Health Canada for advanced prostate cancer in 1989, providing 36 years of proven clinical use in Cana",
        "pubDate": "2025-11-17T12:01:00Z",
        "displayTime": "2025-11-17T12:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cnwgroup.com/915f008039b56738ddadc58747abee7f",
          "originalWidth": 400,
          "originalHeight": 70,
          "caption": "AbbVie Canada (CNW Group/AbbVie Canada)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g8FJh3PbO6RRduof6NpPwQ--~B/aD03MDt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/cnwgroup.com/915f008039b56738ddadc58747abee7f.cf.webp",
              "width": 400,
              "height": 70,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0dSNjqnEwqJfSfcC6kCkKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/915f008039b56738ddadc58747abee7f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CNW Group",
          "url": "http://www.newswire.ca/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lupron-depot-strength-receives-health-120100885.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lupron-depot-strength-receives-health-120100885.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]